BTAI vs FMC · rev $388.0K vs rev $1.63B
BioXcel Therapeutics Inc (BTAI) versus FMC Corporation (FMC) — a side-by-side from cached financials, not a winner call.
BioXcel Therapeutics Inc (BTAI) is a drug manufacturers - specialty & generic company listed on US.
FMC Corporation (FMC) is a agricultural inputs company listed on NYSE.
Latest reported BTAI revenue for 2026-06-30 was $388.0K. Net income was -$27.4M. Revenue was up 88.3% from 2026-03-31 to 2026-06-30. BTAI currently screens at market cap $36.1M.
Latest reported FMC revenue for 2026-06-30 was $1.63B. Net income was -$467.9M. FMC currently screens at market cap $1.50B.
BTAI currently screens at market cap $36.1M. FMC currently screens at market cap $1.50B.
Not investment advice. Open the BTAI and FMC stock pages for the full models.
Not investment advice.